Reported Earlier, Dexcom Announces Stelo, The First Over-The-Counter Glucose Biosensor In The U.S., Is Now Available For Purchase Without A Prescription
Reported Earlier, Dexcom Announces Stelo, The First Over-The-Counter Glucose Biosensor In The U.S., Is Now Available For Purchase Without A Prescription
如今，德康醫療宣佈 Stelo，美國首款非處方葡萄糖生物傳感器已經上市，可以無需處方購買。
- Available for purchase today at Stelo.com for people in the U.S. 18 and older not using insulin
- Provides 24/7 powerful and personalized glucose insights directly to a smartphone,* revealing how food, exercise and sleep can affect glucose
- Tracking glucose just got easier, with no prescription and no fingersticks, ever
- Specifically designed to help people with Type 2 diabetes not using insulin and those with prediabetes reach their A1c goals and potentially slow the progression of diabetes.†,1-3
- Stelo.com現在可供美國18歲及以上人群購買，不使用胰島素
- 提供全天候強大且個性化的血糖信息直接發送到智能手機上，揭示食物、鍛鍊和睡眠如何影響血糖
- 跟蹤血糖變得更加容易，無需處方和指尖採血
- 專門設計幫助不使用胰島素的2型糖尿病患者和患有糖尿病前期的人達到A1c目標，可能延緩糖尿病的進展†,1-3
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription4 at Stelo.com.
全球領先的實時連續血糖監測技術公司DexCom, Inc. (納斯達克：DXCM) 今日宣佈，美國首款非處方式血糖生物傳感器Stelo現可在Stelo.com購買，無需處方4